Kesselheim AS, Avorn J - BMJ
The rapid adoption of new medical devices by “innovator” and “early adopter” surgeons—as demonstrated by half of hip prosthesis brands in use having been on the market less than three years—poses public health risks because most devices are cleared through the 510(k) pathway without clinical effectiveness testing.
VIEW SOURCE
Daval CJR, Kesselheim AS - STAT
Mulsant SS, Kesselheim AS, Naci H - Journal of Cancer Policy
Costa E, Kesselheim AS - Journal of Law, Medicine, & Ethics